Literature DB >> 10647647

Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer.

D K Ornstein1, I A Lubensky, D Venzon, B Zbar, W M Linehan, M M Walther.   

Abstract

PURPOSE: We describe the earliest renal lesions associated with hereditary papillary renal cancer and estimate the prevalence of microscopic papillary renal tumors.
MATERIALS AND METHODS: Grossly normal tissue was obtained from 12 kidneys during renal surgery in 9 patients with hereditary papillary renal cancer. Tissue was examined microscopically and findings were compared to those previously reported to be associated with von Hippel-Lindau disease and sporadic renal cell carcinoma.
RESULTS: A total of 92 microscopic papillary renal cell carcinoma lesions were identified on 46 of 88 slides (53%). No other lesions were identified. All tumors were solid and displayed the basophilic papillary histology characteristic of hereditary papillary renal cancer. Extrapolation of the data predicted the prevalence of 1,100 to 3,400 microscopic papillary tumors in a single kidney in a patient with hereditary papillary renal cancer.
CONCLUSIONS: The basophilic papillary histology characteristic of clinically apparent renal tumors in patients with hereditary papillary renal cancer also characterizes the multiple microscopic lesions seen in the kidneys. These findings suggest that the earliest renal tumor in patients with an activating hereditary mutation of the met gene is papillary basophilic renal cancer. The large number of microscopic tumors in patients with hereditary papillary renal cancer was comparable to or greater than that seen in those with von Hippel-Lindau disease.

Entities:  

Mesh:

Year:  2000        PMID: 10647647

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Papillary renal cell carcinoma in allograft kidney.

Authors:  Catherine Roy; Sofiane El Ghali; Xavier Buy; Véronique Lindner; Afshin Gangi
Journal:  Eur Radiol       Date:  2004-09-17       Impact factor: 5.315

Review 2.  Long-term management of bilateral, multifocal, recurrent renal carcinoma.

Authors:  Gennady Bratslavsky; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 3.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

4.  Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.

Authors:  Gopal N Gupta; James Peterson; Kailash N Thakore; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-05-15       Impact factor: 7.450

5.  Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.

Authors:  Nick W Liu; Kiranpreet Khurana; Sunil Sudarshan; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 6.  Genetic predisposition to kidney cancer.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

7.  Expression of KRT7 and WT1 differentiates precursor lesions of Wilms' tumours from those of papillary renal cell tumours and mucinous tubular and spindle cell carcinomas.

Authors:  Adrianna Szponar; Gyula Kovacs
Journal:  Virchows Arch       Date:  2012-03-02       Impact factor: 4.064

8.  Sciellin is a marker for papillary renal cell tumours.

Authors:  Anetta Nagy; Daniel Banyai; David Semjen; Tamas Beothe; Gyula Kovacs
Journal:  Virchows Arch       Date:  2015-10-16       Impact factor: 4.064

Review 9.  Therapeutic Strategies for Hereditary Kidney Cancer.

Authors:  Abhinav Sidana; Ramaprasad Srinivasan
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

Review 10.  Molecular diagnosis and therapy of kidney cancer.

Authors:  W Marston Linehan; Gennady Bratslavsky; Peter A Pinto; Laura S Schmidt; Len Neckers; Donald P Bottaro; Ramaprasad Srinivasan
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.